Literature DB >> 2648024

Role of hemagglutinin cleavage and expression of M1 protein in replication of A/WS/33, A/PR/8/34, and WSN influenza viruses in mouse brain.

R W Schlesinger1, G L Bradshaw, F Barbone, M Reinacher, R Rott, P Husak.   

Abstract

The combined presence of WSN gene segments 6 (neuraminidase), 7 (M1 and M2), and 8 (NS1 and NS2) in reassortants of WSN with A/Aichi/2/68 (H3N2) has been found by others to be necessary for full expression of neurovirulence in mice. We are examining the expression of the analogous three gene segments in brains of mice after intracerebral infection with non-neuroadapted strains A/WS/33 (WS) (from which WSN was derived) and A/PR/8/34 (PR8). Our aim is to determine possible mechanisms by which one or more of the five gene products may restrict replication of these strains in mouse brain cells to a single cycle, yielding noninfectious hemagglutinating particles (incomplete growth cycle). We found that minority subsets of such particles did produce plaques, provided they were activated by trypsin (analogous to other abortive systems producing virions with uncleaved HA), a step obviated for some WSN virions by indirect promotion of hemagglutinin cleavage by the neuraminidase of that strain. The percentage of such potentially infectious virions, relative to total hemagglutinating particles, was significantly lower in WS- or PR8-infected than in WSN-infected brains, suggesting possible defects in synthesis or function of M1 protein in the former. Cells in immunostained sections and appropriate bands in Western blots (immunoblots) of viral proteins electrophoretically separated from lysates of PR8-infected brains reacted with antibody to nucleoprotein but not to M1 protein. Either method revealed the presence of both proteins in WSN-infected brains. In contrast, Western blot analyses of particles concentrated from PR8-, WS-, or WSN-infected brains by hemadsorption, elution, and pelleting did reveal NP and M1 bands with comparable relative peroxidase-antiperoxidase staining intensities. The findings suggest that availability of M1 protein is a factor influencing the extent or rate of assembly of potentially infectious (i.e., trypsin-activated) progeny virions in mouse brains and that in this respect the two non-neurovirulent strains differ from WSN quantitatively rather than qualitatively.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2648024      PMCID: PMC248424     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  A pantropic strain of influenza virus: generalized infection and viremia in the infant mouse.

Authors:  R R WAGNER
Journal:  Virology       Date:  1955-12       Impact factor: 3.616

2.  The limited growth of influenza viruses in the mouse brain.

Authors:  H J CAIRNS
Journal:  Aust J Exp Biol Med Sci       Date:  1954-02

3.  Polypeptide synthesis in simian virus 5-infected cells.

Authors:  R W Peluso; R A Lamb; P W Choppin
Journal:  J Virol       Date:  1977-07       Impact factor: 5.103

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  1918 influenza, encephalitis lethargica, parkinsonism.

Authors:  R T Ravenholt; W H Foege
Journal:  Lancet       Date:  1982-10-16       Impact factor: 79.321

6.  Biosynthesis of the influenza virus envelope in abortive infection.

Authors:  J Lohmeyer; L T Talens; H D Klenk
Journal:  J Gen Virol       Date:  1979-01       Impact factor: 3.891

7.  Replication of the influenza virus genome.

Authors:  G L Smith; A J Hay
Journal:  Virology       Date:  1982-04-15       Impact factor: 3.616

8.  Neurovirulence of influenza virus in mice. II. Mechanism of virulence as studied in a neuroblastoma cell line.

Authors:  S Nakajima; A Sugiura
Journal:  Virology       Date:  1980-03       Impact factor: 3.616

9.  Pathogenesis of neurovirulent influenza A virus infection in mice. Route of entry of virus into brain determines infection of different populations of cells.

Authors:  M Reinacher; J Bonin; O Narayan; C Scholtissek
Journal:  Lab Invest       Date:  1983-12       Impact factor: 5.662

10.  Mouse neurotropic recombinants of influenza A viruses.

Authors:  J Bonin; C Scholtissek
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

View more
  7 in total

1.  Effects of cell differentiation on replication of A/WS/33, WSN, and A/PR/8/34 influenza viruses in mouse brain cell cultures: biological and immunological characterization of products.

Authors:  G L Bradshaw; R W Schlesinger; C D Schwartz
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

2.  Involvement of non-structural proteins (NS) in influenza A infection and viral tropism.

Authors:  Xinmin Yan; Qiuwei Wang; Zhiqing Zhang; Yiming Xie; Hong Zhang; Miriam Razi; Shen Hu; Lijun Zhang; Jinluo Cheng; Shen Pang
Journal:  Biochem Biophys Res Commun       Date:  2012-10-08       Impact factor: 3.575

3.  Changes in the neuraminidase of neurovirulent influenza virus strains.

Authors:  A C Ward
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

4.  Splenic priming of virus-specific CD8 T cells following influenza virus infection.

Authors:  Damian L Turner; Kara L Bickham; Donna L Farber; Leo Lefrançois
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

5.  DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice.

Authors:  S Kodihalli; H Goto; D L Kobasa; S Krauss; Y Kawaoka; R G Webster
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

6.  Specific changes in the M1 protein during adaptation of influenza virus to mouse.

Authors:  A C Ward
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

7.  Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein define a requirement for dibasic residues for intracellular cleavage.

Authors:  J Y Dong; J W Dubay; L G Perez; E Hunter
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.